NCCN临床实践指南_皮肤鳞状细胞癌（2019.V1）英文版

Squamous Cell Skin Cancer Version 1 2019 August 31 2018 NCCN org NCCN Clinical Practice Guidelines in Oncology NCCN Guidelines Continue Version 1 2019 08 31 18 National Comprehensive Cancer Network Inc 2018 All rights reserved The NCCN Guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN ContinueNCCN Guidelines Panel Disclosures Dermatology Discussion Section Writing Committee Hematology Hematology oncology Internal medicine Medical oncology Otolaryngology Pathology Dermatopathology Reconstructive surgery Radiotherapy Radiation oncology Surgery Surgical oncology NCCN Mary Dwyer MS Anita Engh PhD Lydia Hammond MBA Roy Decker MD PhD Yale Cancer Center Smilow Cancer Hospital Dominick DiMaio MD Fred Hutchinson Cancer Research Center Seattle Cancer Care Alliance Jeffrey M Farma MD Fox Chase Cancer Center Kris Fisher MD v St Jude Children s Research Hospital University of Tennessee Health Science Center Karthik Ghosh MD Mayo Clinic Cancer Center Roy C Grekin MD v UCSF Helen Diller Family Comprehensive Cancer Center Alan L Ho MD PhD Memorial Sloan Kettering Cancer Center J Harrison Howard MD The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute Donald Lawrence MD Massachusetts General Hospital Cancer Center Karl D Lewis MD University of Colorado Cancer Center Manisha Loss MD v Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Kishwer S Nehal MD v Memorial Sloan Kettering Cancer Center Paul Nghiem MD PhD v Fred Hutchinson Cancer Research Center Seattle Cancer Care Alliance Igor Puzanov MD Roswell Park Cancer Institute Chrysalyne D Schmults MD v Dana Farber Brigham and Women s Cancer Center Aleksandar Sekulic MD PhD Mayo Clinic Cancer Center Ashok R Shaha MD z Memorial Sloan Kettering Cancer Center Valencia Thomas MD v The University of Texas MD Anderson Cancer Center Yaohui G Xu MD PhD v University of Wisconsin Carbone Cancer Center John A Zic MD v Vanderbilt Ingram Cancer Center Christopher K Bichakjian MD Chair v University of Michigan Rogel Cancer Center Sumaira Z Aasi MD v Stanford Cancer Institute Murad Alam MD z Robert H Lurie Comprehensive Cancer Center of Northwestern University James S Andersen MD City of Hope Comprehensive Cancer Center Rachel Blitzblau MD PhD Duke Cancer Institute Jeremy Bordeaux MD MPH v Case Comprehensive Cancer Center University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute Glen M Bowen MD v Huntsman Cancer Institute at the University of Utah Pei Ling Chen MD PhD Moffitt Cancer Center Carlo M Contreras MD University of Alabama at Birmingham Comprehensive Cancer Center Mackenzie Daly MD Siteman Cancer Center at Barnes Jewish Hospital and Washington University School of Medicine Gregory A Daniels MD PhD UC San Diego Moores Cancer Center NCCN Guidelines Index Table of Contents Discussion Version 1 2019 08 31 18 National Comprehensive Cancer Network Inc 2018 All rights reserved The NCCN Guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN NCCN Guidelines Version 1 2019 Squamous Cell Skin Cancer Printed by Maria Chen on 9 13 2018 10 24 38 PM For personal use only Not approved for distribution Copyright 2018 National Comprehensive Cancer Network Inc All Rights Reserved NCCN Squamous Cell Skin Cancer Panel Members Summary of the Guidelines Updates SCC Workup and Risk Status SCC 1 Local low risk SCC 2 Local high risk SCC 3 Treatment for Palpable Regional Lymph Nodes or Abnormal Lymph Node s SCC 4 SCC Follow up and Recurrence SCC 6 Principles of Pathology SCC A SCC Risk Factors for Local Recurrence or Metastases SCC B Identification and Management of High Risk Patients SCC C Principles of Treatment for Squamous Cell Skin Cancer SCC D Principles of Radiation Therapy for Squamous Cell Skin Cancer SCC E Staging ST 1 Clinical Trials NCCN believes that the best management for any patient with cancer is in a clinical trial Participation in clinical trials is especially encouraged To find clinical trials online at NCCN Member Institutions click here nccn org clinical trials clinicians aspx NCCN Categories of Evidence and Consensus All recommendations are category 2A unless otherwise indicated See NCCN Categories of Evidence and Consensus The NCCN Guidelines are a statement of evidence and consensus of the authors regarding their views of currently accepted approaches to treatment Any clinician seeking to apply or consult the NCCN Guidelines is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient s care or treatment The National Comprehensive Cancer Network NCCN makes no representations or warranties of any kind regarding their content use or application and disclaims any responsibility for their application or use in any way The NCCN Guidelines are copyrighted by National Comprehensive Cancer Network All rights reserved T